Current and future strategy for antihypertensive medication
Koike, G.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 127(5): 393-398
2006
ISSN/ISBN: 0015-5691 PMID: 16819246 Document Number: 598727
Document emailed within 1 workday
Related Documents
Leinbach, T.R. 1989: The transmigration programme in Indonesian national development strategy: current status and future requirements Habitat International 13(3): 81-93Yokota, K.; Shimada, K. 2011: Characteristics and dosage of antihypertensive medication Nihon Rinsho. Japanese Journal of Clinical Medicine 69(11): 1963-1968
Grégoire, J.P. 1999: Choice of initial antihypertensive medication and continuation of use Canadian Journal of Cardiology 15 Suppl F: 39f-41f
Beuckelmann, D.; Meyer, H.D.; Erdmann, E. 1985: Na+-Li+ countertransport in human erythrocytes--effects of hypokalaemia, oral contraceptives and antihypertensive medication Klinische Wochenschrift 63(Suppl 3): 139-142
Barczok, M. 2009: A comprehensive therapeutic strategy for the asthmatic patient. Medication according to need is not enough MMW Fortschritte der Medizin 151(18): 23-24
Ylihärsilä, H.; Eriksson, J.G.; Forsén, T.; Laakso, M.; Uusitupa, M.; Osmond, C.; Barker, D.J.P. 2004: Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication Journal of Hypertension 22(7): 1283-1287
Bönner, G. 1999: Fat control--an effective antihypertensive strategy. Special recommendations for therapy of the overweight patient MMW Fortschritte der Medizin 141(46): 34-36
Missotten, A.; Amery, A. 1974: Future trends in antihypertensive therapy Acta Clinica Belgica 29(5): 262-269
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
Frank, E.; Grochocinski, V.J.; Spanier, C.A.; Buysse, D.J.; Cherry, C.R.; Houck, P.R.; Stapf, D.M.; Kupfer, D.J. 2000: Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression Journal of Clinical Psychiatry 61(1): 51-57
Jaillon, P. 1986: Current therapeutic concepts in the treatment of myocardial ischemia. Current and future drugs Annales de Cardiologie et d'Angeiologie 35(7 Pt 2): 453-458
Hvelplund, A.; Galatius, Søren.; Madsen, M.; Sørensen, R.; Madsen, J.Kyst.; Iversen, A.Zeeberg.; Tilsted, H-Henrik.; Helqvist, S.; Mortensen, P.Erik.; Nielsen, P.Hostrup.; Prescott, E.; Abildstrøm, S.Zabell. 2012: Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men Journal of Invasive Cardiology 24(1): 19-24
Lung, T.; Jan, S.; de Silva, H.A.; Guggilla, R.; Maulik, P.K.; Naik, N.; Patel, A.; de Silva, A.P.; Rajapakse, S.; Ranasinghe, G.; Prabhakaran, D.; Rodgers, A.; Salam, A.; Selak, V.; Stepien, S.; Thom, S.; Webster, R.; Lea-Laba, T. 2019: Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial LANCET. Global Health 7(10): E1359-E1366
Treska, V. 2016: Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives Anticancer Research 36(5): 2065-2071
Wax, C.M. 1994: A strategy for the future success of osteopathic medicine Journal of the American Osteopathic Association 94(1): 33
Edan, G.; Coustans, M. 2000: Is immunosuppression a future therapeutic strategy for multiple sclerosis? Pathologie-Biologie 48(2): 114-120
Rajzer, M.; Kawecka-Jaszcz, K.; Wojciechowska, W. 2003: Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research Przeglad Lekarski 60(2): 111-115
Gil-Extremera, B.; Ma, P.T.S.; Yulde, J.; Kalnins, U.; Harkin, N.; Williams, L. 2003: The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy International Journal of Clinical Practice 57(10): 861-866
Hannaford, P.; Hunt, J.; Sullivan, F.; Wyke, S. 1999: Shaping the future: a primary care research and development strategy for Scotland Health Bulletin 57(5): 295-299
Stepanian, I.E. 2005: Current possibilities of the treatment of chronic obstructive pulmonary disease: bronchodilating medication of long duration Terapevticheskii Arkhiv 77(3): 82-87